https://www.pharmalive.com/wp-content/uploads/2021/06/U.S.-FDA-approves-Novo-Nordisks-semaglutide-as-obesity-treatment-Reuters-6-4-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-09-25 08:49:392023-09-25 09:20:23Novo Nordisk and Valo to research cardiometabolic treatments
